Quantamental Technologies’s Genomic Health, Inc. GHDX Stock Holding History

Quantamental Technologies’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,405	Closed	-$299K	–	1658
2019 Q3	$299K	Sell	4,405 -681	-13%	-$46.8K	0.1%	349
2019 Q2	$296K	Buy	5,086 +1,754	+53%	+$104K	0.11%	305
2019 Q1	$233K	Buy	3,332 +534	+19%	+$39.6K	0.11%	319
2018 Q4	$180K	Buy	+2,798	New	+$196K	0.11%	340

Quantamental Technologies's GHDX Position: Q4 2019 in Review

Quantamental Technologies sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,405 shares — an estimated $299K sold.

Quantamental Technologies first reported a position in GHDX in Q4 2018 and held it in 4 quarters. The position peaked at $299K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Quantamental Technologies reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Quantamental Technologies sold 4,405 Genomic Health, Inc. shares in Q4 2019, an estimated $299K.
Quantamental Technologies first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 4 quarters.
Quantamental Technologies's Genomic Health, Inc. position peaked at $299K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.